Published in PLoS One on October 10, 2012
Variants in the CXCL12 gene was associated with coronary artery disease susceptibility in Chinese Han population. Oncotarget (2017) 0.75
Association of circulating levels of RANTES and -403G/A promoter polymorphism to acute heart failure after STEMI and to cardiogenic shock. Clin Exp Med (2014) 0.75
Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med (2002) 4.02
RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation (2001) 3.86
Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation (2002) 2.69
Monocyte and macrophage dynamics during atherogenesis. Arterioscler Thromb Vasc Biol (2011) 2.44
Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A (1999) 2.17
Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis (2001) 1.72
Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol (2005) 1.63
Rapid detection of epidermal growth factor receptor mutations in non-small cell lung cancer using real-time polymerase chain reaction with TaqMan-MGB probes. Cancer J (2006) 1.61
Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. Eur Heart J (2004) 1.57
Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol (2000) 1.52
Chemokines in the vascular inflammatory response of atherosclerosis. Cardiovasc Res (2009) 1.45
Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol (2006) 1.34
Genotypic selection methods for the direct analysis of point mutations. Mutat Res (1997) 1.30
RANTES chemokine expression in transplant-associated accelerated atherosclerosis. J Heart Lung Transplant (1996) 1.12
RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients. Atherosclerosis (2005) 1.02
The additive contribution from inflammatory genetic markers on the severity of cardiovascular disease. Scand J Immunol (2009) 0.95
The RANTES -403G>A promoter polymorphism in Korean men: association with serum RANTES concentration and coronary artery disease. Clin Sci (Lond) (2007) 0.92
Genetic polymorphism in the pregnancy-associated plasma protein-A associated with acute myocardial infarction. Coron Artery Dis (2007) 0.88
RANTES/CCL5 and risk for coronary events: results from the MONICA/KORA Augsburg case-cohort, Athero-Express and CARDIoGRAM studies. PLoS One (2011) 0.87
Simultaneous detection of CYP3A5 and MDR1 polymorphisms based on the SNaPshot assay. Clin Biochem (2011) 0.86
Chemokines in vascular pathology (review). Int J Mol Med (2006) 0.86
Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention. Thromb Res (2009) 0.82
Inflammation in coronary artery diseases. Chin Med J (Engl) (2011) 0.82
RANTES gene mRNA expression and its -403 G/A promoter polymorphism in coronary artery disease. Gene (2011) 0.81
CCL5/RANTES gene polymorphisms in Slavonic patients with myocardial infarction. Mediators Inflamm (2011) 0.79
Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway. Cardiovasc Ther (2010) 1.55
Correlation of red cell distribution width with the severity of coronary artery disease: a large Chinese cohort study from a single center. Chin Med J (Engl) (2013) 1.49
Inflammation in variant angina: is there any evidence? Med Hypotheses (2006) 1.48
Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results. Chin Med J (Engl) (2010) 1.40
Two-year clinical outcome after successful implantation of drug-eluting and bare metal stents in diabetic patients: results from a real-world single center registry. Chin Med J (Engl) (2009) 1.39
Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth. FEBS J (2012) 1.28
Genetic variation of Chinese PRRSV strains based on ORF5 sequence. Biochem Genet (2006) 1.26
Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts. Arterioscler Thromb Vasc Biol (2009) 1.22
Percutaneous coronary intervention with anomalous origin of right coronary artery: case reports and literature review. J Geriatr Cardiol (2013) 1.18
Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts. Eur Heart J (2008) 1.15
Upregulation of VEGF in subchondral bone of necrotic femoral heads in rabbits with use of extracorporeal shock waves. Calcif Tissue Int (2007) 1.10
Sonographically guided transthoracic biopsy of peripheral lung and mediastinal lesions: role of contrast-enhanced sonography. J Ultrasound Med (2011) 1.10
Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells. Blood (2002) 1.09
Diacylglycerol kinase delta suppresses ER-to-Golgi traffic via its SAM and PH domains. Mol Biol Cell (2002) 1.08
The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients. Ann Surg Oncol (2013) 1.07
Inflammatory response is associated with aortic dissection. Ageing Res Rev (2008) 1.07
High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients. World J Gastroenterol (2010) 1.06
Profound thrombocytopenia induced by clopidogrel with a prior history of long-term safe administration. World J Cardiol (2010) 1.05
Transcatheter occlusion of the ruptured sinus of Valsalva aneurysm with an Amplatzer duct occluder. Int J Cardiol (2007) 1.04
Transradial versus transfemoral method of percutaneous coronary revascularization for unprotected left main coronary artery disease: comparison of procedural and late-term outcomes. JACC Cardiovasc Interv (2010) 1.04
Temporal and spatial expression of BMP-2 in sub-chondral bone of necrotic femoral heads in rabbits by use of extracorporeal shock waves. Acta Orthop (2008) 1.03
Isolation and identification of an anti-tumor component from leaves of Impatiens balsamina. Molecules (2008) 1.03
Increased red cell distribution width in patients with slow coronary flow syndrome. Clinics (Sao Paulo) (2013) 1.03
Conversion of fatty aldehydes into alk (a/e)nes by in vitro reconstituted cyanobacterial aldehyde-deformylating oxygenase with the cognate electron transfer system. Biotechnol Biofuels (2013) 1.02
Resveratrol in cardiovascular disease: what is known from current research? Heart Fail Rev (2012) 1.01
IL-17A promotes immune cell recruitment in human esophageal cancers and the infiltrating dendritic cells represent a positive prognostic marker for patient survival. J Immunother (2013) 1.00
Plasma concentrations of interleukin-6, C-reactive protein, tumor necrosis factor-α and matrix metalloproteinase-9 in aortic dissection. Clin Chim Acta (2011) 1.00
Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control. Breast Cancer Res Treat (2007) 0.99
Prognostic significance of overexpression of EZH2 and H3k27me3 proteins in gastric cancer. Asian Pac J Cancer Prev (2012) 0.96
Primary intestinal non-Hodgkin's lymphoma: a clinicopathologic analysis of 81 patients. World J Gastroenterol (2011) 0.96
Trogocytosis of MHC-I/peptide complexes derived from tumors and infected cells enhances dendritic cell cross-priming and promotes adaptive T cell responses. PLoS One (2008) 0.95
Catalytic mechanism of C-C hydrolase MhpC from Escherichia coli: kinetic analysis of His263 and Ser110 site-directed mutants. J Mol Biol (2004) 0.94
Fucoidan protects against lipopolysaccharide-induced rat neuronal damage and inhibits the production of proinflammatory mediators in primary microglia. CNS Neurosci Ther (2012) 0.93
The nodular form of hepatic tuberculosis: contrast-enhanced ultrasonographic findings with pathologic correlation. J Ultrasound Med (2010) 0.93
Evaluation of red blood cell distribution width in patients with cardiac syndrome X. Dis Markers (2013) 0.92
Analysis of clinical effect of high-intensity focused ultrasound on liver cancer. World J Gastroenterol (2004) 0.92
Dendritic cell based PSMA immunotherapy for prostate cancer using a CD40-targeted adenovirus vector. PLoS One (2012) 0.92
Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK. Chin J Cancer (2010) 0.91
Short-term impact of low-dose atorvastatin on serum proprotein convertase subtilisin/kexin type 9. Clin Drug Investig (2013) 0.91
Biomarkers in aortic dissection. Clin Chim Acta (2011) 0.90
Sequential chemoradiotherapy with gemcitabine and cisplatin for locoregionally advanced nasopharyngeal carcinoma. Int J Cancer (2012) 0.89
The cortical and striatal gene expression profile of 100 hz electroacupuncture treatment in 6-hydroxydopamine-induced Parkinson's disease model. Evid Based Complement Alternat Med (2012) 0.89
Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease. Lipids Health Dis (2014) 0.89
Glycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable angina. Lipids Health Dis (2014) 0.89
TAP expression reduces IL-10 expressing tumor infiltrating lymphocytes and restores immunosurveillance against melanoma. Int J Cancer (2007) 0.89
Lipid phosphate phosphatases 1 and 3 are localized in distinct lipid rafts. J Biochem (2006) 0.88
Efficacy and safety of leflunomide for the treatment of BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients. Acta Haematol (2013) 0.88
Gastric cancer cell lines induced by trichostatin A. World J Gastroenterol (2008) 0.88
Proprotein convertase subtilisin-kexin type 9 as a biomarker for the severity of coronary artery disease. Ann Med (2015) 0.87
PCSK9: A key factor modulating atherosclerosis. J Atheroscler Thromb (2014) 0.87
Decreased expression of XPO4 is associated with poor prognosis in hepatocellular carcinoma. J Gastroenterol Hepatol (2011) 0.87
[Expression and clinical significance of TESTIN in primary gastric cancer]. Ai Zheng (2008) 0.87
Selective inhibition of carotenoid cleavage dioxygenases: phenotypic effects on shoot branching. J Biol Chem (2008) 0.87
Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin. Cytokine (2007) 0.86
Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma. J Transl Med (2014) 0.86
Simultaneous determination of eight active components in Chinese medicine 'JiangYaBiFeng' tablet by HPLC coupled with diode array detection. J Pharm Biomed Anal (2011) 0.85
Knockdown of focal adhesion kinase reverses colon carcinoma multicellular resistance. Cancer Sci (2009) 0.85
Determination of melamine by flow injection analysis based on chemiluminescence system. Food Chem (2011) 0.84
Gastrin acting on the cholecystokinin2 receptor induces cyclooxygenase-2 expression through JAK2/STAT3/PI3K/Akt pathway in human gastric cancer cells. Cancer Lett (2013) 0.84
Fluvastatin inhibits the expression of tumor necrosis factor-alpha and activation of nuclear factor-kappaB in human endothelial cells stimulated by C-reactive protein. Clin Chim Acta (2005) 0.84
The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease. Clin Cardiol (2011) 0.84
[The prevalence and its screening methods of primary open angle glaucoma in defined population-based study of rural and urban in Beijing]. Zhonghua Yan Ke Za Zhi (2004) 0.84
Synthetic 6-aryl-2-hydroxy-6-ketohexa-2,4-dienoic acid substrates for C-C hydrolase BphD: investigation of a general base catalytic mechanism. Org Biomol Chem (2004) 0.83
Portal vein embolization induces compensatory hypertrophy of remnant liver. World J Gastroenterol (2006) 0.83
Enhancing anti-inflammatory cytokine IL-10 may be beneficial for acute coronary syndrome. Med Hypotheses (2005) 0.83
Impact of admission triglyceride for early outcome in diabetic patients with stable coronary artery disease. Lipids Health Dis (2014) 0.83
Prognostic Value of Coronary Artery Stenoses, Markis Class, and Ectasia Ratio in Patients with Coronary Artery Ectasia. Cardiology (2015) 0.83
Relation of leukocytes and its subsets counts with the severity of stable coronary artery disease in patients with diabetic mellitus. PLoS One (2014) 0.83
Prognostic significance of hERG1 expression in gastric cancer. Dig Dis Sci (2009) 0.83
Cloning, characterization and application of a glyceraldehyde-3-phosphate dehydrogenase promoter from Aspergillus terreus. J Ind Microbiol Biotechnol (2013) 0.82
Is systemic inflammation responsible for coronary artery ectasia? Int J Cardiol (2008) 0.82